ANGO · AngioDynamics, Inc.

On April 23, 2026, AngioDynamics initiated a patent infringement lawsuit against Endovascular Engineering (E2) in the U.S. District Court for the District of Delaware. The complaint alleges that E2's Hēlo Thrombectomy System incorporates features protected by AngioDynamics' registered patents, particularly relating to self-expanding funnel technology for thrombus and emboli removal. AngioDynamics is seeking damages and equitable relief, underscoring its commitment to enforcing intellectual property rights. This legal action could have significant implications for AngioDynamics' competitive position in the thrombectomy market, as it challenges a rival product. However, litigation outcomes are uncertain, and the company may incur substantial legal costs. Investors should monitor developments, as a favorable ruling could strengthen AngioDynamics' market position, while an adverse outcome or prolonged litigation could divert resources and create uncertainty.